Clinical Trial Update: Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

View source ↗

Summary

The EVADIAB study evaluating myocardial perfusion heterogeneity imaging in type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Type 2 Diabetes | Status: COMPLETED